3 Most Active Penny Stocks to Watch Today, 7/16/2026Tip Ranks·Jul 16 at 09:52 AMSOBR+13.21%ERNA-10.34%
Ernexa Therapeutics climbs 7% during regular trading to $6.47US Stock Market Update·Jul 15 at 12:52 PMERNA-10.34%
Dow Gains Over 150 Points; Morgan Stanley Profit Tops Viewsbenzinga_article·Jul 15 at 08:43 AM.DJI-1.05%ERNA-10.34%
Ernexa Therapeutics surges 40% intraday after 88% premarket jumpUS Stock Market Update·Jul 15 at 08:41 AMERNA-10.34%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Jul 15 at 07:05 AMVTAK+1.26%NXTC-3.41%
Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry | ERNA Stock NewsStockTitan·Jul 14 at 10:50 PMERNA-10.34%
Ernexa Therapeutics SVP of Finance Sandra Gurrola resigns effective July 3PUBT·Jun 26 at 03:31 PMERNA-10.34%
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients | ERNA Stock NewsStockTitan·Jun 25 at 12:15 AMERNA-10.34%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jun 18 at 07:06 AMLNAI-5.75%NVCR+29.67%
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study | ERNA Stock NewsStockTitan·Jun 16 at 11:47 PMERNA-10.34%
